Maroie Barkati

High-Dose-Rate Brachytherapy as a Monotherapy for Favorable-Risk Prostate Cancer: A Phase II Trial

Maroie Barkati, Scott Williams, Farshad Foroudi et al. · International Journal of Radiation Oncology*Biology*Physics · 2011 · 121 citations

Medicine, Radiation Oncology, Urology +14

Consensus Recommendations for Radiation Therapy Contouring and Treatment of Vulvar Carcinoma

David K. Gaffney, Bronwyn King, Akila N. Viswanathan et al. · International Journal of Radiation Oncology*Biology*Physics · 2016 · 111 citations

Medicine, Oncology, Radiation Oncology +16

Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial

Chris Parker, Howard Kynaston, Adrian Cook et al. · The Lancet · 2024 · 72 citations · Full text

Medicine, Oncology, Urology +15

Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial

Chris Parker, Noel W. Clarke, Adrian Cook et al. · The Lancet · 2024 · 49 citations · Full text

Medicine, Oncology, Surgery +15

DEVIL, VAAD and vLSC constitute a spectrum of HPV‐independent, p53‐independent intra‐epithelial neoplasia of the vulva

Simon F. Roy, Jahg Wong, Cécile Le Page et al. · Histopathology · 2021 · 34 citations

Medicine, Oncology, Pathology +17